Keep checking back for new content

Prostate Cancer Vaccine Found Not To Improve Survival

by Jim Barney on July 2, 2018


Prostvac-V/F, an investigational prostate cancer vaccine regimen, does not improve overall survival among men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer, according to the findings of the phase 3 PROSPECT trial.

Read the article here.

{ 0 comments… add one now }

Previous post:

Next post: